PAIN+ CPN

Pelletier F, Gallais Serezal I, Puyraveau M, et al. Electromyography-guided botulinum toxin injections in provoked vestibulodynia: a randomized double-blind placebo-controlled clinical trial. Am J Obstet Gynecol. 2026 May;234(5):1362-1369. doi: 10.1016/j.ajog.2025.12.037. Epub 2025 Dec 17. (Original study)
Abstract

BACKGROUND: Provoked vestibulodynia is a prevalent and complex disease with a major effect on women's quality of life. This condition is often associated with abnormal reflexes and muscle hypertonicity. Local injections of Onabotulinum toxin A guided by electromyography have been reported as a promising therapeutic possibility, although randomized controlled trials are lacking.

OBJECTIVE: To assess the efficacy of electromyography-guided Onabotulinum toxin A in provoked vestibulodynia. The primary endpoint was a modification of the pain visual analog scale after treatment.

STUDY DESIGN: This randomized, double-blind trial compared electromyography-guided injections of Onabotulinum toxin A (50 units) vs placebo into the superficial perineal muscles. Patients were randomized and received electromyography-guided injections of either saline or Onabotulinum toxin A (50 U on each side in superficial perineal muscles). Data on pain (assessed using a visual analog scale), quality of life (measured by the Dermatology Life Quality Index), and quality of sex life (assessed using the Female Sexual Function Index) were collected before treatment and 3 and 6 months after injection.

RESULTS: Sixty patients were randomized. The mean±standard deviation age was 26.1±0.8 years. After 3 months, the pain visual analog scale decreased in the treated group to 5.04±0.61 vs 7.37±0.45 in the placebo group (P=.008). The Dermatology Life Quality Index differed in the treatment and placebo groups at 3 and 6 months (P<.01 and P=.03, respectively). In the Female Sexual Function Index evaluation, the scores of the items "sexual satisfaction" and "sexual desire" were higher in the treated group than in the placebo group (P=.05 and .01, respectively).

CONCLUSION: Onabotulinum toxin A injections were effective on the pain, quality of life, and sexual functions of the patients. We suggest that muscular dysfunction is a key element of vestibulodynia pain. Electromyography-guided Onabotulinum toxin A injections were associated with improvement of symptoms in provoked vestibulodynia.

Ratings
Discipline Area Score
Physician 5 / 7
Comments from MORE raters

Physician rater

Vestibulodynia is such a commonly encountered condition, but often not frequently discussed in medical meetings. Helpful review that explains some of the more common ideologies (pelvic floor dysfunction) and potential treatment with botulinum.
Comments from PAIN+ CPN subscribers

No subscriber has commented on this article yet.